Skip to content

Long-term Effect of Low Frequency Stimulation on Aspiration and Freezing of Gait in PD With STN DBS

Long-term Effect of Low Frequency 60Hz Stimulation on Aspiration, Freezing of Gait and Other Axial and Motor Symptoms in PD Patients With Bilateral STN DBS

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02549859
Enrollment
11
Registered
2015-09-15
Start date
2015-08-31
Completion date
2017-05-31
Last updated
2020-10-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's Disease

Keywords

DBS, Low frequency stimulation, Dysphagia, Freezing of gait

Brief summary

Our recent study (Xie et al, Neurology 2015; 84: 415-420) found that bilateral STN DBS of 60Hz, compared to the traditional 130Hz, decreased the aspiration frequency and swallowing difficulty, freezing of gait (FOG), and other axial symptoms and parkinsonism in Parkinson patients with FOG refractory to 130Hz and medications. The benefit of 60Hz stimulation persisted during the 6-week study period, but with worsening tremor in one patient. However, it remains unknown whether the benefit of 60Hz would persist on prolonged stimulation period, and whether there is carry-over effect across different conditions. Hence, the investigators would like to test the hypothesis that the 60Hz stimulation, compared to 130Hz might have persistent benefit over an extended period in reducing the swallowing dysfunction, FOG, and other axial symptoms in these PD patients even after correcting the potential carry-over effect.

Detailed description

The investigators will enroll 14 Parkinson patients with bilateral STN DBS and refractory FOG to 130Hz stimulation and dopaminergic medications for two visits of at least 6-month apart. The 6 patients remaining on 60Hz stimulation after our previous study consisting of 7 patients will be assessed once again as visit-2 after previous visit-1 of their last study. We anticipate to have 20 patents complete for visit-1 and at least 18 patients complete for visit-2 in this randomized double-blind prospective crossover study with their usual medication on state, with 6-7 patients on each starting condition (60Hz vs 130Hz vs DBS off). Swallowing function on modified barium swallowing test and swallowing questionnaire, FOG in stand-walk-sit test and questionnaire, and other axial and motor function on UPDRS-III will be assessed under each DBS condition. Changes in measurements between 60Hz and 130Hz at each visit and under 60Hz between two visits will be analyzed, with swallowing function and FOG as primary, and the rest as secondary outcomes, correcting for potential carryover effect. Changes between other DBS conditions might also be explored in this 2-year study. This would be the first study on the long-term effect of 60Hz stimulation on dysphagia, FOG and other axial and motor symptoms in Parkinson patients with bilateral STN DBS and FOG refractory to 130Hz stimulation and dopaminergic medications, which will have significant impact on the treatment of difficult axial symptoms of high morbidity and mortality.

Interventions

DEVICEDeep Brain Stimulation (DBS) at 60 Hz

Bilateral subthalamic nucleus deep brain stimulation at 60 Hz

DEVICEDeep Brain Stimulation (DBS) at 130 Hz

Bilateral subthalamic nucleus deep brain stimulation at 130 Hz

DEVICEDeep Brain Stimulation (DBS) Off (Sham)

Deep Brain Stimulation (DBS) Off (Sham)

Sponsors

Michael J. Fox Foundation for Parkinson's Research
CollaboratorOTHER
University of Chicago
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
45 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* PD patients with bilateral STN DBS placement and FOG at 130Hz even at usual medication on state.

Exclusion criteria

* Known history of recent aspiration pneumonia

Design outcomes

Primary

MeasureTime frameDescription
Stand-Walk-Sit Time at Visit 2Immediately following treatment for at least 30 minutesStand-Walk-Sit (SWS) Time measures the total time taken to complete the SWS test of standing up, walking 7 meters, and returning to a sitting position. The longer time (in seconds) it took to complete the SWS test, the worse the FOG symptoms.
Frequency of Aspiration Events on Videofluoroscopic Swallow Study at Visit 1Immediately following treatment for at least 30 minutesA speech pathologist used the Penetration-Aspiration Scale (PAS) to rate swallows captured by a radiologist during VFSS recording. PAS is an 8-point interval scale: a score of 0 indicates no penetration or aspiration & a score of 6-8 indicates aspiration of increasing severity. For the purpose of this study, aspiration was dichotomized to 0 if PAS score was under 6 or 1 if PAS score was between 6-8. Frequency of aspiration events was calculated by adding number of aspiration events in VFSS under various liquid & food textures. The maximum aspiration frequency was 12 if aspiration occurred on every texture after 2 trials. Lower aspiration frequency means better swallowing function.
Perceived Swallowing Difficulty on Swallowing Disturbance Questionnaire at Visit 1Immediately following treatment for at least 30 minutesThe Swallowing Disturbance Questionnaire contains 15 items. Each item has 4-points ranging from 0 (absence of symptoms) to 3 (severe or very frequent). Total score ranges from 0-45, with higher scores corresponding to more severe swallowing disturbance.
Freezing of Gait Questionnaire at Visit 1Immediately following treatment for at least 30 minutesThe Freezing of Gait (FOG) Questionnaire contains 6 items to evaluate the severity of FOG in patients with Parkinson's disease. Each item has 5 points ranging from 0 (absence of symptoms) to 4 (severe). Total score ranges from 0-24, with higher scores corresponding to more severe FOG.
Stand-Walk-Sit Freezing of Gait Spells at Visit 1Immediately following treatment for at least 30 minutesThe Stand-Walk-Sit (SWS) Test assesses freezing of gait (FOG) spells observed when standing up, walking 7 meters, and returning to a seated position. The greater the number of FOG spells counted, the worse the FOG symptoms.
Stand-Walk-Sit Time at Visit 1Immediately following treatment for at least 30 minutesStand-Walk-Sit (SWS) Time measures the total time taken to complete the SWS test of standing up, walking 7 meters, and returning to a sitting position. The longer time (in seconds) it took to complete the SWS test, the worse the FOG symptoms.
Frequency of Aspiration Events on Videofluoroscopic Swallow Study at Visit 2Immediately following treatment for at least 30 minutesA speech pathologist used the Penetration-Aspiration Scale (PAS) to rate swallows captured by a radiologist during VFSS recording. PAS is an 8-point interval scale: a score of 0 indicates no penetration or aspiration & a score of 6-8 indicates aspiration of increasing severity. For the purpose of this study, aspiration was dichotomized to 0 if PAS score was under 6 or 1 if PAS score was between 6-8. Frequency of aspiration events was calculated by adding number of aspiration events in VFSS under various liquid & food textures. The maximum aspiration frequency was 12 if aspiration occurred on every texture after 2 trials. Lower aspiration frequency means better swallowing function.
Perceived Swallowing Difficulty on Swallowing Disturbance Questionnaire at Visit 2Immediately following treatment for at least 30 minutesThe Swallowing Disturbance Questionnaire contains 15 items. Each item has 4-points ranging from 0 (absence of symptoms) to 3 (severe or very frequent). Total score ranges from 0-45, with higher scores corresponding to more severe swallowing disturbance.
Freezing of Gait Questionnaire at Visit 2Immediately following treatment for at least 30 minutesThe Freezing of Gait (FOG) Questionnaire contains 6 items to evaluate the severity of FOG in patients with Parkinson's disease. Each item has 5 points ranging from 0 (absence of symptoms) to 4 (severe). Total score ranges from 0-24, with higher scores corresponding to more severe FOG.
Stand-Walk-Sit Freezing of Gait Spells at Visit 2Immediately following treatment for at least 30 minutesThe Stand-Walk-Sit (SWS) Test assesses freezing of gait (FOG) spells observed when standing up, walking 7 meters, and returning to a seated position. The greater the number of FOG spells counted, the worse the FOG symptoms.

Secondary

MeasureTime frameDescription
Unified Parkinson's Disease Rating Scale-III Total Score at Visit 1Immediately following treatment for at least 30 minutesUnified Parkinson's Disease Rating Scale-III (UPDRS-III) contains 33 items. Each item has 5-points ranging from 0 (absence of symptoms) to 4 (severe). Total score ranges from 0-132, with higher scores corresponding to more severe parkinsonism.
Axial Subscore of Unified Parkinson's Disease Rating Scale-III at Visit 1Immediately following treatment for at least 30 minutesThe axial subscore of Unified Parkinson's Disease Rating Scale-III (UPDRS-III) contains 7 items. Each item has 5-points ranging from 0 (absence of symptoms) to 4 (severe). Total score ranges from 0-28, with higher scores corresponding to more severe axial symptoms. Specifically, axial symptoms include: speech, facial expression, arising from chair, gait, freezing of gait, postural stability, posture.
Bradykinesia Subscore of Unified Parkinson's Disease Rating Scale-III at Visit 1Immediately following treatment for at least 30 minutesThe bradykinesia subscore of Unified Parkinson's Disease Rating Scale-III (UPDRS-III) contains 11 items. Each item has 5-points ranging from 0 (absence of symptoms) to 4 (severe). Total score ranges from 0-44, with higher scores corresponding to more severe bradykinesia. Specifically, bradykinesia symptoms include: finger tapping right hand, finger tapping left hand, hand movements right hand, hand movements left hand, pronation-supination movements right hand, pronation- supination movements left hand, toe tapping right foot, toe tapping left foot, leg agility right leg, leg agility left leg, global spontaneity of movement.
Rigidity Subscore of Unified Parkinson's Disease Rating Scale-III at Visit 1Immediately following treatment for at least 30 minutesThe rigidity subscore of Unified Parkinson's Disease Rating Scale-III (UPDRS-III) contains 5 items. Each item has 5-points ranging from 0 (absence of symptoms) to 4 (severe). Total score ranges from 0-20. with higher scores corresponding to more severe rigidity. Specifically, rigidity symptoms include: rigidity neck, rigidity right upper extremity, rigidity left upper extremity, rigidity right lower extremity, rigidity left lower extremity.
Tremor Subscore of Unified Parkinson's Disease Rating Scale-III at Visit 1Immediately following treatment for at least 30 minutesThe tremor subscore of Unified Parkinson's Disease Rating Scale (UPDRS-III) contains 10 items. Each item has 5-points ranging from 0 (absence of symptoms) to 4 (severe). Total score ranges from 0-40, with higher scores corresponding to more severe tremor. Specifically, tremor symptoms include: postural tremor right hand, postural tremor left hand, kinetic tremor right hand, kinetic tremor left hand, rest tremor amplitude right upper extremity, rest tremor amplitude left upper extremity, rest tremor amplitude right lower extremity, rest tremor amplitude left lower extremity, rest tremor amplitude lip/jaw, constancy of rest tremor.
Unified Parkinson's Disease Rating Scale-III Total Score at Visit 2Immediately following treatment for at least 30 minutesUnified Parkinson's Disease Rating Scale-III (UPDRS-III) contains 33 items. Each item has 5-points ranging from 0 (absence of symptoms) to 4 (severe). Total score ranges from 0-132, with higher scores corresponding to more severe parkinsonism.
Axial Subscore of Unified Parkinson's Disease Rating Scale-III at Visit 2Immediately following treatment for at least 30 minutesThe axial subscore of Unified Parkinson's Disease Rating Scale-III (UPDRS-III) contains 7 items. Each item has 5-points ranging from 0 (absence of symptoms) to 4 (severe). Total score ranges from 0-28, with higher scores corresponding to more severe axial symptoms. Specifically, axial symptoms include: speech, facial expression, arising from chair, gait, freezing of gait, postural stability, posture.
Bradykinesia Subscore of Unified Parkinson's Disease Rating Scale-III at Visit 2Immediately following treatment for at least 30 minutesThe bradykinesia subscore of Unified Parkinson's Disease Rating Scale-III (UPDRS-III) contains 11 items. Each item has 5-points ranging from 0 (absence of symptoms) to 4 (severe). Total score ranges from 0-44, with higher scores corresponding to more severe bradykinesia. Specifically, bradykinesia symptoms include: finger tapping right hand, finger tapping left hand, hand movements right hand, hand movements left hand, pronation-supination movements right hand, pronation- supination movements left hand, toe tapping right foot, toe tapping left foot, leg agility right leg, leg agility left leg, global spontaneity of movement.
Rigidity Subscore of Unified Parkinson's Disease Rating Scale-III at Visit 2Immediately following treatment for at least 30 minutesThe rigidity subscore of Unified Parkinson's Disease Rating Scale-III (UPDRS-III) contains 5 items. Each item has 5-points ranging from 0 (absence of symptoms) to 4 (severe). Total score ranges from 0-20. with higher scores corresponding to more severe rigidity. Specifically, rigidity symptoms include: rigidity neck, rigidity right upper extremity, rigidity left upper extremity, rigidity right lower extremity, rigidity left lower extremity.
Tremor Subscore of Unified Parkinson's Disease Rating Scale-III at Visit 2Immediately following treatment for at least 30 minutesThe tremor subscore of Unified Parkinson's Disease Rating Scale (UPDRS-III) contains 10 items. Each item has 5-points ranging from 0 (absence of symptoms) to 4 (severe). Total score ranges from 0-40, with higher scores corresponding to more severe tremor. Specifically, tremor symptoms include: postural tremor right hand, postural tremor left hand, kinetic tremor right hand, kinetic tremor left hand, rest tremor amplitude right upper extremity, rest tremor amplitude left upper extremity, rest tremor amplitude right lower extremity, rest tremor amplitude left lower extremity, rest tremor amplitude lip/jaw, constancy of rest tremor.

Countries

United States

Participant flow

Recruitment details

15 patients were screened for eligibility at a hospital-associated specialty clinic in Chicago, IL.

Pre-assignment details

Eleven of 15 screened participants were enrolled; four did not meet inclusion/exclusion criteria. Five of the enrolled participants had participated in a previous study and had been treated on 60Hz DBS since then; their Visit 1 (V1) measurements were taken from the previous study.

Participants by arm

ArmCount
Deep Brain Stimulation (DBS)
All patients were treated and assessed under three conditions (60 Hz DBS, 130 Hz DBS and no DBS) at Visit 1 (V1), were then treated with 60 Hz DBS for at least 6 months (14.5 months on average), and were finally reassessed during a second visit (V2) under the same three conditions as V1. The order of treatment/assessment under the three conditions was randomized at each visit.
11
Total11

Withdrawals & dropouts

PeriodReasonFG000
Long-term 60 Hz DBSStudy Closed1

Baseline characteristics

CharacteristicDeep Brain Stimulation (DBS)
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
9 Participants
Age, Categorical
Between 18 and 65 years
2 Participants
DBS at High Frequency Stimulation Duration3.5 years
STANDARD_DEVIATION 4
Parkinson's Disease Duration14.2 years
STANDARD_DEVIATION 5.7
Race/Ethnicity, Customized
Asian
1 participants
Race/Ethnicity, Customized
Black
0 participants
Race/Ethnicity, Customized
Hispanic or Latino
4 participants
Race/Ethnicity, Customized
White, non-Hispanic
6 participants
Region of Enrollment
United States
11 participants
Sex: Female, Male
Female
2 Participants
Sex: Female, Male
Male
9 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 110 / 110 / 11
other
Total, other adverse events
0 / 110 / 110 / 11
serious
Total, serious adverse events
0 / 110 / 110 / 11

Outcome results

Primary

Freezing of Gait Questionnaire at Visit 1

The Freezing of Gait (FOG) Questionnaire contains 6 items to evaluate the severity of FOG in patients with Parkinson's disease. Each item has 5 points ranging from 0 (absence of symptoms) to 4 (severe). Total score ranges from 0-24, with higher scores corresponding to more severe FOG.

Time frame: Immediately following treatment for at least 30 minutes

Population: Participants completing Visit 1

ArmMeasureValue (MEAN)Dispersion
DBS 60HzFreezing of Gait Questionnaire at Visit 13.0 score on a scaleStandard Deviation 3.7
DBS 130HzFreezing of Gait Questionnaire at Visit 19.3 score on a scaleStandard Deviation 4.1
DBS OffFreezing of Gait Questionnaire at Visit 15.1 score on a scaleStandard Deviation 3.8
p-value: <0.01Paired t-test, 2 sided
Primary

Freezing of Gait Questionnaire at Visit 2

The Freezing of Gait (FOG) Questionnaire contains 6 items to evaluate the severity of FOG in patients with Parkinson's disease. Each item has 5 points ranging from 0 (absence of symptoms) to 4 (severe). Total score ranges from 0-24, with higher scores corresponding to more severe FOG.

Time frame: Immediately following treatment for at least 30 minutes

Population: Participants completing Visit 2

ArmMeasureValue (MEAN)Dispersion
DBS 60HzFreezing of Gait Questionnaire at Visit 25.9 score on a scaleStandard Deviation 4.4
DBS 130HzFreezing of Gait Questionnaire at Visit 211.2 score on a scaleStandard Deviation 4.1
DBS OffFreezing of Gait Questionnaire at Visit 27.0 score on a scaleStandard Deviation 4
p-value: <0.01Paired t-test, 2 sided
Primary

Frequency of Aspiration Events on Videofluoroscopic Swallow Study at Visit 1

A speech pathologist used the Penetration-Aspiration Scale (PAS) to rate swallows captured by a radiologist during VFSS recording. PAS is an 8-point interval scale: a score of 0 indicates no penetration or aspiration & a score of 6-8 indicates aspiration of increasing severity. For the purpose of this study, aspiration was dichotomized to 0 if PAS score was under 6 or 1 if PAS score was between 6-8. Frequency of aspiration events was calculated by adding number of aspiration events in VFSS under various liquid & food textures. The maximum aspiration frequency was 12 if aspiration occurred on every texture after 2 trials. Lower aspiration frequency means better swallowing function.

Time frame: Immediately following treatment for at least 30 minutes

Population: Participants completing Visit 1

ArmMeasureValue (MEAN)Dispersion
DBS 60HzFrequency of Aspiration Events on Videofluoroscopic Swallow Study at Visit 10.6 score on a scaleStandard Deviation 0.8
DBS 130HzFrequency of Aspiration Events on Videofluoroscopic Swallow Study at Visit 12.9 score on a scaleStandard Deviation 2.1
DBS OffFrequency of Aspiration Events on Videofluoroscopic Swallow Study at Visit 11.2 score on a scaleStandard Deviation 1.7
p-value: <0.05Paired t-test, 2 sided
Primary

Frequency of Aspiration Events on Videofluoroscopic Swallow Study at Visit 2

A speech pathologist used the Penetration-Aspiration Scale (PAS) to rate swallows captured by a radiologist during VFSS recording. PAS is an 8-point interval scale: a score of 0 indicates no penetration or aspiration & a score of 6-8 indicates aspiration of increasing severity. For the purpose of this study, aspiration was dichotomized to 0 if PAS score was under 6 or 1 if PAS score was between 6-8. Frequency of aspiration events was calculated by adding number of aspiration events in VFSS under various liquid & food textures. The maximum aspiration frequency was 12 if aspiration occurred on every texture after 2 trials. Lower aspiration frequency means better swallowing function.

Time frame: Immediately following treatment for at least 30 minutes

Population: Participants completing Visit 2

ArmMeasureValue (MEAN)Dispersion
DBS 60HzFrequency of Aspiration Events on Videofluoroscopic Swallow Study at Visit 22.0 score on a scaleStandard Deviation 2.4
DBS 130HzFrequency of Aspiration Events on Videofluoroscopic Swallow Study at Visit 23.0 score on a scaleStandard Deviation 2.5
DBS OffFrequency of Aspiration Events on Videofluoroscopic Swallow Study at Visit 22.4 score on a scaleStandard Deviation 2.6
p-value: >0.05Paired t-test, 2 sided
Primary

Perceived Swallowing Difficulty on Swallowing Disturbance Questionnaire at Visit 1

The Swallowing Disturbance Questionnaire contains 15 items. Each item has 4-points ranging from 0 (absence of symptoms) to 3 (severe or very frequent). Total score ranges from 0-45, with higher scores corresponding to more severe swallowing disturbance.

Time frame: Immediately following treatment for at least 30 minutes

Population: Participants completing Visit 1

ArmMeasureValue (MEAN)Dispersion
DBS 60HzPerceived Swallowing Difficulty on Swallowing Disturbance Questionnaire at Visit 11.1 score on a scaleStandard Deviation 1
DBS 130HzPerceived Swallowing Difficulty on Swallowing Disturbance Questionnaire at Visit 13.3 score on a scaleStandard Deviation 2.1
DBS OffPerceived Swallowing Difficulty on Swallowing Disturbance Questionnaire at Visit 13.1 score on a scaleStandard Deviation 1.9
p-value: <0.01Paired t-test, 2 sided
Primary

Perceived Swallowing Difficulty on Swallowing Disturbance Questionnaire at Visit 2

The Swallowing Disturbance Questionnaire contains 15 items. Each item has 4-points ranging from 0 (absence of symptoms) to 3 (severe or very frequent). Total score ranges from 0-45, with higher scores corresponding to more severe swallowing disturbance.

Time frame: Immediately following treatment for at least 30 minutes

Population: Participants completing Visit 2

ArmMeasureValue (MEAN)Dispersion
DBS 60HzPerceived Swallowing Difficulty on Swallowing Disturbance Questionnaire at Visit 24.8 score on a scaleStandard Deviation 6.9
DBS 130HzPerceived Swallowing Difficulty on Swallowing Disturbance Questionnaire at Visit 27.4 score on a scaleStandard Deviation 8.9
DBS OffPerceived Swallowing Difficulty on Swallowing Disturbance Questionnaire at Visit 25.7 score on a scaleStandard Deviation 6.9
p-value: >0.05Paired t-test, 2 sided
Primary

Stand-Walk-Sit Freezing of Gait Spells at Visit 1

The Stand-Walk-Sit (SWS) Test assesses freezing of gait (FOG) spells observed when standing up, walking 7 meters, and returning to a seated position. The greater the number of FOG spells counted, the worse the FOG symptoms.

Time frame: Immediately following treatment for at least 30 minutes

Population: Participants completing Visit 1

ArmMeasureValue (MEAN)Dispersion
DBS 60HzStand-Walk-Sit Freezing of Gait Spells at Visit 10.1 score on a scaleStandard Deviation 0.2
DBS 130HzStand-Walk-Sit Freezing of Gait Spells at Visit 13.0 score on a scaleStandard Deviation 3.8
DBS OffStand-Walk-Sit Freezing of Gait Spells at Visit 11.6 score on a scaleStandard Deviation 1.6
p-value: >0.05Paired t-test, 2 sided
Primary

Stand-Walk-Sit Freezing of Gait Spells at Visit 2

The Stand-Walk-Sit (SWS) Test assesses freezing of gait (FOG) spells observed when standing up, walking 7 meters, and returning to a seated position. The greater the number of FOG spells counted, the worse the FOG symptoms.

Time frame: Immediately following treatment for at least 30 minutes

Population: Participants completing Visit 2

ArmMeasureValue (MEAN)Dispersion
DBS 60HzStand-Walk-Sit Freezing of Gait Spells at Visit 22.2 score on a scaleStandard Deviation 3.8
DBS 130HzStand-Walk-Sit Freezing of Gait Spells at Visit 26.1 score on a scaleStandard Deviation 7
DBS OffStand-Walk-Sit Freezing of Gait Spells at Visit 22.5 score on a scaleStandard Deviation 2.8
p-value: <0.05Paired t-test, 2 sided
Primary

Stand-Walk-Sit Time at Visit 1

Stand-Walk-Sit (SWS) Time measures the total time taken to complete the SWS test of standing up, walking 7 meters, and returning to a sitting position. The longer time (in seconds) it took to complete the SWS test, the worse the FOG symptoms.

Time frame: Immediately following treatment for at least 30 minutes

Population: Participants completing Visit 1

ArmMeasureValue (MEAN)Dispersion
DBS 60HzStand-Walk-Sit Time at Visit 122.1 secondsStandard Deviation 7.1
DBS 130HzStand-Walk-Sit Time at Visit 128.5 secondsStandard Deviation 8.5
DBS OffStand-Walk-Sit Time at Visit 123.6 secondsStandard Deviation 6
p-value: <0.05Paired t-test, 2 sided
Primary

Stand-Walk-Sit Time at Visit 2

Stand-Walk-Sit (SWS) Time measures the total time taken to complete the SWS test of standing up, walking 7 meters, and returning to a sitting position. The longer time (in seconds) it took to complete the SWS test, the worse the FOG symptoms.

Time frame: Immediately following treatment for at least 30 minutes

Population: Participants completing Visit 2

ArmMeasureValue (MEAN)Dispersion
DBS 60HzStand-Walk-Sit Time at Visit 226.5 secondsStandard Deviation 12.2
DBS 130HzStand-Walk-Sit Time at Visit 238.4 secondsStandard Deviation 26
DBS OffStand-Walk-Sit Time at Visit 227.8 secondsStandard Deviation 11.9
p-value: >0.05Paired t-test, 2 sided
Secondary

Axial Subscore of Unified Parkinson's Disease Rating Scale-III at Visit 1

The axial subscore of Unified Parkinson's Disease Rating Scale-III (UPDRS-III) contains 7 items. Each item has 5-points ranging from 0 (absence of symptoms) to 4 (severe). Total score ranges from 0-28, with higher scores corresponding to more severe axial symptoms. Specifically, axial symptoms include: speech, facial expression, arising from chair, gait, freezing of gait, postural stability, posture.

Time frame: Immediately following treatment for at least 30 minutes

Population: Participants completing Visit 1

ArmMeasureValue (MEAN)Dispersion
DBS 60HzAxial Subscore of Unified Parkinson's Disease Rating Scale-III at Visit 13.8 score on a scaleStandard Deviation 3.3
DBS 130HzAxial Subscore of Unified Parkinson's Disease Rating Scale-III at Visit 18.9 score on a scaleStandard Deviation 3.4
DBS OffAxial Subscore of Unified Parkinson's Disease Rating Scale-III at Visit 16.9 score on a scaleStandard Deviation 4.4
p-value: <0.001Paired t-test, 2 sided
Secondary

Axial Subscore of Unified Parkinson's Disease Rating Scale-III at Visit 2

The axial subscore of Unified Parkinson's Disease Rating Scale-III (UPDRS-III) contains 7 items. Each item has 5-points ranging from 0 (absence of symptoms) to 4 (severe). Total score ranges from 0-28, with higher scores corresponding to more severe axial symptoms. Specifically, axial symptoms include: speech, facial expression, arising from chair, gait, freezing of gait, postural stability, posture.

Time frame: Immediately following treatment for at least 30 minutes

Population: Participants completing Visit 2

ArmMeasureValue (MEAN)Dispersion
DBS 60HzAxial Subscore of Unified Parkinson's Disease Rating Scale-III at Visit 26.8 score on a scaleStandard Deviation 4.7
DBS 130HzAxial Subscore of Unified Parkinson's Disease Rating Scale-III at Visit 210.4 score on a scaleStandard Deviation 3.9
DBS OffAxial Subscore of Unified Parkinson's Disease Rating Scale-III at Visit 28.1 score on a scaleStandard Deviation 4
p-value: <0.05Paired t-test, 2 sided
Secondary

Bradykinesia Subscore of Unified Parkinson's Disease Rating Scale-III at Visit 1

The bradykinesia subscore of Unified Parkinson's Disease Rating Scale-III (UPDRS-III) contains 11 items. Each item has 5-points ranging from 0 (absence of symptoms) to 4 (severe). Total score ranges from 0-44, with higher scores corresponding to more severe bradykinesia. Specifically, bradykinesia symptoms include: finger tapping right hand, finger tapping left hand, hand movements right hand, hand movements left hand, pronation-supination movements right hand, pronation- supination movements left hand, toe tapping right foot, toe tapping left foot, leg agility right leg, leg agility left leg, global spontaneity of movement.

Time frame: Immediately following treatment for at least 30 minutes

Population: Participants completing Visit 1

ArmMeasureValue (MEAN)Dispersion
DBS 60HzBradykinesia Subscore of Unified Parkinson's Disease Rating Scale-III at Visit 111.7 score on a scaleStandard Deviation 5.3
DBS 130HzBradykinesia Subscore of Unified Parkinson's Disease Rating Scale-III at Visit 116.6 score on a scaleStandard Deviation 4.6
DBS OffBradykinesia Subscore of Unified Parkinson's Disease Rating Scale-III at Visit 117.1 score on a scaleStandard Deviation 5
p-value: <0.05Paired t-test, 2 sided
Secondary

Bradykinesia Subscore of Unified Parkinson's Disease Rating Scale-III at Visit 2

The bradykinesia subscore of Unified Parkinson's Disease Rating Scale-III (UPDRS-III) contains 11 items. Each item has 5-points ranging from 0 (absence of symptoms) to 4 (severe). Total score ranges from 0-44, with higher scores corresponding to more severe bradykinesia. Specifically, bradykinesia symptoms include: finger tapping right hand, finger tapping left hand, hand movements right hand, hand movements left hand, pronation-supination movements right hand, pronation- supination movements left hand, toe tapping right foot, toe tapping left foot, leg agility right leg, leg agility left leg, global spontaneity of movement.

Time frame: Immediately following treatment for at least 30 minutes

Population: Participants completing Visit 2

ArmMeasureValue (MEAN)Dispersion
DBS 60HzBradykinesia Subscore of Unified Parkinson's Disease Rating Scale-III at Visit 212.8 score on a scaleStandard Deviation 3.5
DBS 130HzBradykinesia Subscore of Unified Parkinson's Disease Rating Scale-III at Visit 216.3 score on a scaleStandard Deviation 2.3
DBS OffBradykinesia Subscore of Unified Parkinson's Disease Rating Scale-III at Visit 215.7 score on a scaleStandard Deviation 3.7
p-value: <0.05Paired t-test, 2 sided
Secondary

Rigidity Subscore of Unified Parkinson's Disease Rating Scale-III at Visit 1

The rigidity subscore of Unified Parkinson's Disease Rating Scale-III (UPDRS-III) contains 5 items. Each item has 5-points ranging from 0 (absence of symptoms) to 4 (severe). Total score ranges from 0-20. with higher scores corresponding to more severe rigidity. Specifically, rigidity symptoms include: rigidity neck, rigidity right upper extremity, rigidity left upper extremity, rigidity right lower extremity, rigidity left lower extremity.

Time frame: Immediately following treatment for at least 30 minutes

Population: Participants completing Visit 1

ArmMeasureValue (MEAN)Dispersion
DBS 60HzRigidity Subscore of Unified Parkinson's Disease Rating Scale-III at Visit 14.0 score on a scaleStandard Deviation 2.4
DBS 130HzRigidity Subscore of Unified Parkinson's Disease Rating Scale-III at Visit 14.9 score on a scaleStandard Deviation 2.5
DBS OffRigidity Subscore of Unified Parkinson's Disease Rating Scale-III at Visit 16.0 score on a scaleStandard Deviation 3.1
p-value: >0.05Paired t-test, 2 sided
Secondary

Rigidity Subscore of Unified Parkinson's Disease Rating Scale-III at Visit 2

The rigidity subscore of Unified Parkinson's Disease Rating Scale-III (UPDRS-III) contains 5 items. Each item has 5-points ranging from 0 (absence of symptoms) to 4 (severe). Total score ranges from 0-20. with higher scores corresponding to more severe rigidity. Specifically, rigidity symptoms include: rigidity neck, rigidity right upper extremity, rigidity left upper extremity, rigidity right lower extremity, rigidity left lower extremity.

Time frame: Immediately following treatment for at least 30 minutes

Population: Participants completing Visit 2

ArmMeasureValue (MEAN)Dispersion
DBS 60HzRigidity Subscore of Unified Parkinson's Disease Rating Scale-III at Visit 24.3 score on a scaleStandard Deviation 2.2
DBS 130HzRigidity Subscore of Unified Parkinson's Disease Rating Scale-III at Visit 23.8 score on a scaleStandard Deviation 2.1
DBS OffRigidity Subscore of Unified Parkinson's Disease Rating Scale-III at Visit 24.8 score on a scaleStandard Deviation 2.4
p-value: >0.05Paired t-test, 2 sided
Secondary

Tremor Subscore of Unified Parkinson's Disease Rating Scale-III at Visit 1

The tremor subscore of Unified Parkinson's Disease Rating Scale (UPDRS-III) contains 10 items. Each item has 5-points ranging from 0 (absence of symptoms) to 4 (severe). Total score ranges from 0-40, with higher scores corresponding to more severe tremor. Specifically, tremor symptoms include: postural tremor right hand, postural tremor left hand, kinetic tremor right hand, kinetic tremor left hand, rest tremor amplitude right upper extremity, rest tremor amplitude left upper extremity, rest tremor amplitude right lower extremity, rest tremor amplitude left lower extremity, rest tremor amplitude lip/jaw, constancy of rest tremor.

Time frame: Immediately following treatment for at least 30 minutes

Population: Participants completing Visit 1

ArmMeasureValue (MEAN)Dispersion
DBS 60HzTremor Subscore of Unified Parkinson's Disease Rating Scale-III at Visit 11.8 score on a scaleStandard Deviation 2.2
DBS 130HzTremor Subscore of Unified Parkinson's Disease Rating Scale-III at Visit 11.2 score on a scaleStandard Deviation 2.1
DBS OffTremor Subscore of Unified Parkinson's Disease Rating Scale-III at Visit 12.5 score on a scaleStandard Deviation 3.4
p-value: >0.05Paired t-test, 2 sided
Secondary

Tremor Subscore of Unified Parkinson's Disease Rating Scale-III at Visit 2

The tremor subscore of Unified Parkinson's Disease Rating Scale (UPDRS-III) contains 10 items. Each item has 5-points ranging from 0 (absence of symptoms) to 4 (severe). Total score ranges from 0-40, with higher scores corresponding to more severe tremor. Specifically, tremor symptoms include: postural tremor right hand, postural tremor left hand, kinetic tremor right hand, kinetic tremor left hand, rest tremor amplitude right upper extremity, rest tremor amplitude left upper extremity, rest tremor amplitude right lower extremity, rest tremor amplitude left lower extremity, rest tremor amplitude lip/jaw, constancy of rest tremor.

Time frame: Immediately following treatment for at least 30 minutes

Population: Participants completing Visit 2

ArmMeasureValue (MEAN)Dispersion
DBS 60HzTremor Subscore of Unified Parkinson's Disease Rating Scale-III at Visit 21.6 score on a scaleStandard Deviation 2.6
DBS 130HzTremor Subscore of Unified Parkinson's Disease Rating Scale-III at Visit 20.2 score on a scaleStandard Deviation 0.7
DBS OffTremor Subscore of Unified Parkinson's Disease Rating Scale-III at Visit 21.2 score on a scaleStandard Deviation 2
p-value: >0.05Paired t-test, 2 sided
Secondary

Unified Parkinson's Disease Rating Scale-III Total Score at Visit 1

Unified Parkinson's Disease Rating Scale-III (UPDRS-III) contains 33 items. Each item has 5-points ranging from 0 (absence of symptoms) to 4 (severe). Total score ranges from 0-132, with higher scores corresponding to more severe parkinsonism.

Time frame: Immediately following treatment for at least 30 minutes

Population: Participants completing Visit 1

ArmMeasureValue (MEAN)Dispersion
DBS 60HzUnified Parkinson's Disease Rating Scale-III Total Score at Visit 122.8 score on a scaleStandard Deviation 10.4
DBS 130HzUnified Parkinson's Disease Rating Scale-III Total Score at Visit 133.7 score on a scaleStandard Deviation 8.3
DBS OffUnified Parkinson's Disease Rating Scale-III Total Score at Visit 134.4 score on a scaleStandard Deviation 12.1
p-value: <0.01Paired t-test, 2 sided
Secondary

Unified Parkinson's Disease Rating Scale-III Total Score at Visit 2

Unified Parkinson's Disease Rating Scale-III (UPDRS-III) contains 33 items. Each item has 5-points ranging from 0 (absence of symptoms) to 4 (severe). Total score ranges from 0-132, with higher scores corresponding to more severe parkinsonism.

Time frame: Immediately following treatment for at least 30 minutes

Population: Participants completing Visit 2

ArmMeasureValue (MEAN)Dispersion
DBS 60HzUnified Parkinson's Disease Rating Scale-III Total Score at Visit 227.1 score on a scaleStandard Deviation 9.1
DBS 130HzUnified Parkinson's Disease Rating Scale-III Total Score at Visit 232.4 score on a scaleStandard Deviation 7.1
DBS OffUnified Parkinson's Disease Rating Scale-III Total Score at Visit 231.4 score on a scaleStandard Deviation 10.1
p-value: <0.05Paired t-test, 2 sided

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026